ArticleCurrent oncology (Toronto, Ont.)2025

A Dramatic Clinical Response to Trastuzumab-Deruxtecan in a Patient with HER-2 Low Breast Cancer with Untreated Leptomeningeal Metastasis and Hydrocephalus.

Sarah Hussain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.